Filter options:

Freebase Commons Common /common

  • Zanamivir powder, for respiratory (inhalation) administration, consisting of: 5mg zanamivir.Indications:RELENZA, an influenza neuraminidase inhibitor, is indicated for: Treatment of influenza in patients 7 years of age and older who have been symptomatic for no more than 2 days. (1.1) Prophylaxis of influenza in patients 5 years of age and older. (1.2) Important Limitations on Use of RELENZA: Not recommended for treatment or prophylaxis of influenza in: Individuals with underlying airways disease. (5.1) Not proven effective for: Treatment in individuals with underlying airways disease. (1.3)Prophylaxis in nursing home residents. (1.3) Not a substitute for annual influenza vaccination. (1.3) Consider available information on influenza drug susceptibility patterns and treatment effects when deciding whether to use RELENZA. (1.3)

Freebase Commons Medicine /medicine

Strength value Strength units Active ingredient Drug formulations available in this strength
  • mg
  • -